These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 7791703)

  • 1. [Anemia of prematurity: risk factors influencing red cell transfusions].
    Zuppa AA; Mazzotta M; Maragliano G; Girlando P; Florio MG; Tortorolo G
    Minerva Pediatr; 1995; 47(1-2):13-8. PubMed ID: 7791703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin and prematurity--where do we stand?
    Carbonell-Estrany X; Figueras-Aloy J; Alvarez E
    J Perinat Med; 2005; 33(4):277-86. PubMed ID: 16207112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of erythropoietin in the treatment of anemia of prematurity. Influence of birth weight].
    Carbonell Estrany X; Figueras Aloy J; Pérez Fernández JM; Fernández López A; González Luis G; Salvía Roiges MD
    An Esp Pediatr; 1999 Sep; 51(3):281-6. PubMed ID: 10575752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human erythropoietin in the treatment of anemia of prematurity.
    Chen JY; Wu TS; Chanlai SP
    Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability on red blood cell transfusion practices among Brazilian neonatal intensive care units.
    dos Santos AM; Guinsburg R; Procianoy RS; Sadeck Ldos S; Netto AA; Rugolo LM; Luz JH; Bomfim O; Martinez FE; de Almeida MF;
    Transfusion; 2010 Jan; 50(1):150-9. PubMed ID: 19709390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with red blood cell transfusions in very-low-birth-weight preterm infants in Brazilian neonatal units.
    dos Santos AM; Guinsburg R; de Almeida MF; Procianoy RS; Marba ST; Ferri WA; Rugolo LM; Lopes JM; Moreira ME; Luz JH; González MR; Meneses Jdo A; da Silva RV; Abdallah VO; Duarte JL; Marques PF; Rego MA; Alves Filho N; Krebs VL;
    BMC Pediatr; 2015 Sep; 15():113. PubMed ID: 26341125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth, efficacy, and safety of feeding an iron-fortified human milk fortifier.
    Berseth CL; Van Aerde JE; Gross S; Stolz SI; Harris CL; Hansen JW
    Pediatrics; 2004 Dec; 114(6):e699-706. PubMed ID: 15545616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human erythropoietin in anemia of prematurity.
    Whitehall JS; Patole SK; Campbell P
    Indian Pediatr; 1999 Jan; 36(1):17-27. PubMed ID: 10709119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of recombinant human erythropoietin and risk of severe retinopathy in extremely low-birth-weight infants.
    Schneider JK; Gardner DK; Cordero L
    Pharmacotherapy; 2008 Nov; 28(11):1335-40. PubMed ID: 18956993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A management guideline to reduce the frequency of blood transfusion in very-low-birth-weight infants.
    Rabe H; Alvarez JR; Lawn C; Seddon P; Amess PN
    Am J Perinatol; 2009 Mar; 26(3):179-83. PubMed ID: 19085812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing the anemia of prematurity: red blood cell transfusions versus recombinant erythropoietin.
    Strauss RG
    Transfus Med Rev; 2001 Jul; 15(3):213-23. PubMed ID: 11471123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the need for transfusion of premature infants and role of hematocrit, clinical signs, and erythropoietin level.
    Keyes WG; Donohue PK; Spivak JL; Jones MD; Oski FA
    Pediatrics; 1989 Sep; 84(3):412-7. PubMed ID: 2771544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the practice of transfusion in the anemia in preterm infants].
    Elguazzar S; Alaoui AM; Izgua AT
    Rev Med Brux; 2013; 34(1):4-11. PubMed ID: 23534309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in red blood cell transfusions using a bedside analyzer in extremely low birth weight infants.
    Madan A; Kumar R; Adams MM; Benitz WE; Geaghan SM; Widness JA
    J Perinatol; 2005 Jan; 25(1):21-5. PubMed ID: 15496875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human erythropoietin and blood transfusion in low-birth weight preterm infants under restrictive transfusion guidelines.
    Badiee Z; Pourmirzaiee MA; Kelishadi R; Naseri F
    Saudi Med J; 2006 Jun; 27(6):817-20. PubMed ID: 16758042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human erythropoietin therapy for treatment of anemia of prematurity in very low birth weight infants: a randomized, double-blind, placebo-controlled trial.
    Kumar P; Shankaran S; Krishnan RG
    J Perinatol; 1998; 18(3):173-7. PubMed ID: 9659643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of transfusions in extremely low-birthweight infants in the erythropoietin era.
    Hosono S; Mugishima H; Shimada M; Minato M; Okada T; Takahashi S; Harada K
    Pediatr Int; 2006 Dec; 48(6):572-6. PubMed ID: 17168976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of neonatal anemia with recombinant human erythropoietin: a cost-benefit analysis].
    Schefels J; Merz U; Hörnchen H
    Z Geburtshilfe Neonatol; 1999 Dec; 203 Suppl 2():1-5. PubMed ID: 10612190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative cohort study on transfusion practice and outcome in two Dutch tertiary neonatal centres.
    Khodabux CM; Hack KE; von Lindern JS; Brouwers H; Walther FJ; Brand A
    Transfus Med; 2009 Aug; 19(4):195-201. PubMed ID: 19706136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors of retinopathy of prematurity in newborns treated in neonatal intensive care unit of University Children's Hospital Collegium Medicum Jagiellonian University].
    Głowacka E; Kwinta P; Mitkowska Z; Kobylarz J; Kamińska-Mroczkowska H; Mazurek M; Sadowska M; Pietrzyk JJ
    Przegl Lek; 2002; 59 Suppl 1():86-90. PubMed ID: 12108084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.